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ABSTRACT 
Bioresponsive hydrogels are emerging with technological significance in targeted 
drug delivery, biosensors and regenerative medicine.  Conferred with the ability to 
respond to specific biologically derived stimuli, the design challenge is in effectively 
linking the conferred biospecificity with an engineered response tailored to the needs of a 
particular application. Moreover, the fundamental phenomena governing the response 
must support an appropriate dynamic range and limit of detection. The design of these 
systems is inherently complicated due to the high interdependency of the governing 
phenomena that guide the sensing, transduction, and the actuation response of hydrogels.  
To investigate the dynamics of these materials, model systems may be used which seek to 
interrogate the system dynamics by uni-variable experimentation and limit confounding 
phenomena such as: polymer-solute interactions, polymer swelling dynamics and 
biomolecular reaction-diffusion concerns.   
To this end, a model system, α-chymotrypsin (Cht) (a protease) and a cleavable 
peptide-chromogen (pro-drug) covalently incorporated into a hydrogel, was investigated 
to understand the mechanisms of covalent loading and release by enzymatic cleavage in 
bio-responsive delivery systems. Using EDC and Sulfo-NHS, terminal carboxyl groups 
of N-succinyl-Ala-Ala-Pro-Phe p-nitroanilide, a cleavable chromogen, were conjugated 
to primary amines of a hydrated poly(HEMA)-based hydrogel. Hydrogel discs were 
incubated in buffered Cht causing enzyme-mediated cleavage of the peptide and 
concomitant release of the chromophore for monitoring.  To investigate substrate loading 
and the effects of hydrogel morphology on the system, the concentration of the amino 
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groups (5, 10, 20, and 30 mol%) and the cross-linked density (1, 5, 7, 9 and 12 mol%) 
were independently varied. Loading-Release Efficiency of the chromogen was shown to 
exhibit a positive relation to increasing amino groups (AEMA). The release rates 
demonstrated a negative relation to increasing cross-linked density attributed to 
decreasing void fractions and increasing tortuosities. The diffusion coefficient of Cht, 
D0,Cht, was determined to be 6.9 ± 0.5 × 10-7 cm2 s-1, and the range of Deff of Cht for 1 to 
12 mol% TEGDA was determined to 6.9 ×10-8 to 0.1 × 10-8cm2 s-1. We show how these 
parameters may be optimized and used to achieve programmed release rates in 
engineered bio-responsive systems. 
The field of bioresponsive hydrogels is continuing to expand as the need for such 
materials persists.  Future work will enable more control over the loading and release of 
therapeutic and diagnostic moieties.  Continued research regarding in enzymatically 
actuated hydrogels will involve pre-polymerization loading methodologies; in silico 
diffusion-reaction multiphysics modeling; enzyme actuated degradation of the polymer; 
and substation of various mediating enzyme, cleavable peptides, and release molecules. 
 
  
v 
 
TABLE OF CONTENTS 
                 Page 
ACKNOWLEDGMENTS .................................................................................................. ii 
ABSTRACT ....................................................................................................................... iii 
LIST OF FIGURES ........................................................................................................... vi 
LIST OF FIGURES .......................................................................................................... vii 
LIST OF FIGURES ......................................................................................................... viii 
LIST OF TABLES ...............................................................................................................x 
CHAPTER 1:  BIORESPONSIVE HYDROGELS .............................................................1 
1.1. INTRODUCTION...............................................................................................................1 
1.2. FUNDAMENTAL PHENOMENA EFFECTS RESPONSE .........................................................3 
1.2.1. BIOLOGICAL EVENT, TRANSDUCTION-SIGNAL CREATION,  
AND RESPONSE ................................................................................................. 3 
1.2.2. PHENOMENA GOVERNING RESPONSES .................................................... 5 
1.3. RESPONSE TYPES .........................................................................................................17 
1.3.1 SWELLING OR COLLAPSE - PH AND IONIC ACTUATION .......................... 17 
1.3.2 EROSION AND DEGRADATION ................................................................ 21 
1.3.3 RELEASE ................................................................................................ 23 
1.3.4 MECHANICAL ......................................................................................... 25 
1.3.5 OPTICAL ................................................................................................ 26 
vi 
 
1.3.6 ELECTROCHEMICAL ............................................................................... 28 
1.4. REMARKS AND CONCLUSIONS ......................................................................................29 
CHAPTER 2:  BIOACTIVE HYDROGELS DEMONSTRATE MEDIATED 
RELEASE OF A CHROMOPHORE BY CHYMOTRYPSIN  .................................................30 
2.1.  INTRODUCTION ............................................................................................................30 
2.2.  MATERIAL AND METHODS ..........................................................................................33 
2.2.1 HYDROGEL DISK FORMULATION AND CHARACTERIZATION .................. 33 
2.2.2  CONTROLLED RELEASE OF CHROMOPHORE FROM HYDROGEL .............. 38 
2.2.3  ENZYME AND CHROMOPHORE CHARACTERIZATION ............................. 39 
2.3.  RESULTS AND DISCUSSIONS ........................................................................................39 
2.3.1  ENZYME AND CHROMOPHORE CHARACTERIZATION ............................. 39 
2.3.2 EFFECT OF CONJUGATING AMINE GROUPS ON LOADING ....................... 40 
2.3.2 EFFECT OF CROSS-LINKED DENSITY ON RELEASE .................................. 43 
2.3.3 USING THIELE MODULI TO OPTIMIZE DRUG DELIVERY  
SYSTEMS ........................................................................................... 49 
2.4. REMARKS AND CONCLUSIONS ......................................................................................51 
CHAPTER 3:  FUTURE WORK ...............................................................................................53 
REFERENCES ..................................................................................................................55 
 
 
vii 
 
LIST OF FIGURES 
Page 
Figure 1:  Information flow scheme of bio-responsive hydrogels…………………..……3 
Figure 2:  Interdependency of fundamental phenomena in  
bioresponsive hydrogels…………………………………………..……………….5 
Figure 3:  Comparison of experimental to theoretical results for a  
pH responsive chitosan hydrogel from a FEM approach………………..……….20 
Figure 4:  A bioresponsive hydrogel which gels in situ and 
degrades when exposed to collagenase…………..……………………………....23 
Figure 5: Temperature, pH, and chemically responsive hydrogel  
which changes shape from an elliptical to a spherical  
configuration based on environmental conditions [114]………………………...26 
Figure 6:  DNA sensing bioresponsive, quantum dot loaded hydrogel 
which elicits a shift in its peak absorbance upon exposure  
to the complimentary target DNA [120]…………………………………….…...27 
Figure 7:  Silicone Isolator (Left), Hydrated 5% TEGDA/30%  
AEMA Hydrogel from Study B diameter (Center)  
and thickness (Right) dimensions……………………………………………...36 
 
viii 
 
Figure 8:  Schematic of hydrogel preparation and chromophore  
release process.  (1)  Cross-linking of hydrogel components  
to create disks.  (2)  Solvent extraction and hydration of 
hydrogel disks.  (3)  Covalently linkage of  
chromophore to hydrogel by EDC/Sulfo-NHS chemistry.   
(4) Removal of unreacted chromophore and reagents leaving  
only cross-linked chromophore.  (5) Incubation of hydrogel 
disks in chymotrypsin solution releasing chromogen which 
is measured with UV-Vis spectroscopy……………………………..…………...38 
Figure 9:  (A) A plot of the released concentration of chromophore 
after cleavage of its peptide sequence by chymotrypsin  
as a function AEMA mol%.  (B) A plot of the void  
fraction (left y-axis) and release rate (right y-axis) as a function 
 of AEMA mol%.  (C) A plot of EL-R of the chromogen  
after cleavage of its conjugated peptide sequence by  
chymotrypsin as a function of AEMA mol%, and the  
spectrum scan of p-Nitroanilide after it has been cleaved  
from the peptide sequence……………………………………………...………..41 
ix 
 
Figure 10:  (A)  A plot of the released concentration of chromophore  
after cleavage of its peptide sequence by chymotrypsin  
as a function TEGDA mol%.  (B) A plot of the void fraction  
(left y-axis) and tortuosity (right y-axis) as a function of  
TEGDA mol%..  (C) A plot of the release rates of the  
chromophore after cleavage of its conjugated peptide  
sequence by chymotrypsin as a function of TEGDA mol%..................................45 
Figure 11:  A plot of the maximum characteristic dimension of a  
hydrogel which will not have mass transport limitations as a 
function of effective diffusivity and KM Vmax-1………………………………...50 
 
  
x 
 
LIST OF TABLES 
Page 
Table 1:  Diffusive transport theories as they apply to hydrogel  
morphology……………………………………………………………..…………8 
Table 2:  Empirical and Semi-empirical models for solute diffusion 
 in hydrogels………………………………………………………………….......10 
Table 3: Explicitly derived equations and time approximations for 
diffusive transport of species from hydrogel……………………………….……12 
Table 4:  Hydrogel compositions for Studies A and B………………………………….35 
Table 5: Calculated parameters for varying cross-linked densities  
determined from the analysis of experimentally 
measured rate data………………………………………………………………..47
1 
 
CHAPTER 1:  BIORESPONSIVE HYDROGELS 
1.1. Introduction 
Biologically responsive (bioresponsive) hydrogels are a progressive iteration on 
stimuli responsive hydrogels wherein the response of the hydrogel is mediated by a 
biological recognition reaction. Hydrogel responses include, among others; swelling or 
collapsing, degradation or erosion, mechanical deformation, optical density variations, or 
electrokinetic variations [1]. Bio-responsive hydrogels link hydrogel responses to the 
innate specificity of bio-recognition reactions, and they are designed to elicit a predicted 
response when subjected to a biological agent [2]. Biological agents used to trigger 
engineered responses may be biomolecules like glucose [3], large macromolecules like 
chymotrypsin [4], or even whole cells, such as vascular endothelial cells [5, 6]. The 
response may be binary, as in presence or absence of the biological agent at a particular 
threshold limit, or it may be scalable with the chemical potential or activity of the 
biological agent [7-9]. Highly-specific recognition creates many opportunities for design 
of applications wherein a response will only occur when certain criteria have been met.  
This creates a “smart” material because it is cognizant of surrounding agents and can 
remain in stasis or become dynamic depending on changes in the surrounding 
environment [10, 11]. Bioresponsive hydrogels may share features with but are 
distinguished from biomimetic hydrogels that contain elements of chemistry, structure, 
architecture, morphology and materials properties intended to mimic local biological 
properties and from bioactive hydrogels that contain elements intended to participate 
within known biochemical pathways. 
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The utility of bioresponsive hydrogels is vividly apparent in their applications. 
These hydrogels have been used in tissue engineering [12, 13], in mediated drug delivery 
[14-16], and biosensing applications [17-19]. In tissue engineering, bioresponsive 
hydrogels have been used as biomimetic matrices, which promote cellular proliferation 
but also biodegrade over time . In drug delivery, it is commonly desired to deliver a drug 
in specified doses to a specific site, organ, or biological system [20-22].  Bio-responsive 
hydrogels are capable of location specific delivery because they are able to release the 
therapeutic drug payload when they are triggered by biologically derived, site-specific 
stimuli [23]. In sensor applications, bioresponsive hydrogels can produce a measurable 
response when a specific analyte of biological origin is present [24]  
Although bioresponsive hydrogels have many potential applications and 
advantages, the engineering of these materials is often difficult due to the need for 
considerable molecular and architectural design; the biologically imposed constraints in 
conditions of materials processing; the complex interactions between the hydrogel 
matrix, the conferring bioactive species, the targeted biological agent, and the solvent 
(usually water) during performance. Successful design requires approaches that include 
multiple length scale theoretical and experimental modeling. Theoretical modeling of the 
bioresponsive hydrogels is advantageous as generalized models can be broadly applied; 
however, this approach requires detailed understanding of the interdependence of 
governing phenomena over multiple length scales [25-27] Conversely, empirical 
modeling can yield simple mathematical relations established from analysis of 
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experimental data, but careful considerations must accompany extrapolation of such 
empirical models to other systems or beyond the experimentally probed regimes [28, 29].  
1.2. Fundamental Phenomena Effects Response 
1.2.1. Biological Event, Transduction-Signal Creation, and Response 
Before the governing phenomena and design considerations for bioresponsive 
hydrogels are addressed, the general mechanism for which a biological agent creates a 
response within a hydrogel will first be presented and discussed. The overarching 
platform technology may be considered as arising from the first three-steps illustrated in 
the process flow diagram of Figure 1. 
Figure 1:  Information flow scheme of bio-responsive hydrogels. 
First, a targeted biological agent comes into contact with the hydrogel and is 
“sensed” by a biorecognition species within the hydrogel; the species being specific to 
that agent. Bioactive species can be biomacromolecules like enzymes, antibodies, nucleic 
acids, or any native or synthetic biomimetic variants of the foregoing [30-33], or small 
molecules such as metabolites or peptides [34, 35].  The second step is transduction of 
the sensed agent into a perturbation of the thermodynamic equilibrium of the 
bioresponsive hydrogel system. One example would be where a substrate (targeted 
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biological agent) diffuses into a bioresponsive hydrogel conferred with the specificity of 
an immobilized enzyme which then catalyzes the conversion of that substrate to a 
product. The enzymatic reaction is forced away from equilibrium by a change in the 
chemical potential of the substrate that manifests a change in the chemical potential of the 
product. In bioresponsive hydrogels this perturbation is considered the signal which then 
elicits a response [1]. To establish a response, the hydrogel system must move to a new 
thermodynamic equilibrium based on the newly transduced conditions.  For the case of 
the enzyme, this would be the chemical potential of the substrate motivated by catalysis 
of the substrate to product which will continue until all substrate is consumed or until the 
reaction reaches chemical equilibrium. The change in chemical potential of the product 
may elicit a collapse or swelling of the hydrogel. In this way, the chemical potential of a 
targeted agent is linked via a biorecognition reaction to a response of the hydrogel.  An 
additional step, Step 4, an integrated control loop, is also illustrated in Figure 1 and 
discussed in the subsequent section. For example, the appearance of the product may 
induce a collapse of the hydrogel which reduces the diffusivity of the substrate into the 
hydrogel; in which case the chemical potential of the substrate will have a self-limiting 
effect on the response of the hydrogel. 
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1.2.2. Phenomena Governing Responses 
Figure 2:  Interdependency of fundamental phenomena in bioresponsive hydrogels. 
Bioresponsive hydrogels display a high degree of interdependency between 
response reaction kinetics, associated mass transport, and the kinetics and 
thermodynamics of the response phenomena, usually swelling or deswelling. This 
interdependency is useful because it allows for a wide range of ways to sense, transduce, 
and respond; however, it also necessitates a comprehensive understanding of the system 
because of the dynamic nature of interdependent phenomena. Figure 2 shows the 
dominant governing phenomena and associated governing equations and schematically 
traces through the interdependency of these phenomena in bioresponsive hydrogels. To 
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understand the dynamics of bioresponsive hydrogels, the three governing phenomena will 
be analyzed separately, and then their interdependencies will be considered. 
1.2.2.1. Governing Phenomena – Reaction Kinetics 
For bioresponsive hydrogels two widely used sensing mechanisms are enzymatic 
catalysis and receptor-ligand binding[2].  The fundamental equations commonly used to 
describe these reactions are Michales-Menten and Scatchard equations, respectively. The 
kinetics of these reactions are the limiting case for all other processes in the response.  If 
all other steps in the process occurred instantaneously, which is rarely the case, the 
maximum rate for which the bio-responsive hydrogel could respond would be the 
maximum rate of the catalytic or binding reaction. 
Although both enzymatic and binding reactions are well studied, the kinetics of 
these reactions can be modified by association with the hydrogel.  In some systems the 
enzyme or receptor may be covalently immobilized. This immobilization may cause 
inactivation due to non-specific absorption or protein denaturation [36, 37].  In other 
immobilization techniques the bio-macromolecule may be entrapped within the hydrogel.  
This also may change the kinetics because the bio-macromolecule activity may be 
reduced during immobilization [38].  While immobilization can reduce activity, it often 
increases stability over time and tradeoffs between the two should be considered in 
design.  For bio-responsive hydrogels, the kinetics of bio-macromolecules inside the 
hydrogel should be studied in conjunction with the kinetics of these molecules in solution 
to ascertain the effects the hydrogel environment has on the bio-macromolecule. 
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For the case of any reaction that is not zero order, the effects that mass transport 
limitations or thermodynamic changes in the hydrogel may have on the reaction kinetics 
of the bio-macromolecule should be considered.  Mass transport may affect the kinetics 
because it can reduce the amount of substrate available for reaction [36].  The 
thermodynamics of the hydrogel will govern the hydration and swelling of the gel, and 
because the activity of bio-macromolecules can be affected by the amount of water 
present, the thermodynamics can directly affect the kinetics of the biomolecular reaction 
[39]. 
1.2.2.2. Governing Phenomena – Mass Transport 
Transport within bio-responsive hydrogels directly affects the time dependent 
response of these materials by changing the local availability of bioactive moieties.  The 
rate of transport in and out of a hydrogel can be influenced by diffusion, convection, or 
electrical gradients and is described by the Nernst-Plank equation [40-44]. 
Diffusive transport, the most prevalent mode of transport in hydrogels, occurs via the 
water-filled pores/voids and fundamentally is driven by chemical potential gradients; 
however, in practice concentration gradients are used.  Ficks first and second law are the 
basis for diffusive transport.  Improvement to Ficks law has required diffusion 
coefficients which depend on concentration or polymer properties [45].  These models 
include the free volume theory, hydrodynamic theory, and obstruction theory [46].  Free 
volume theory considers diffusion as a process which solute molecules hop into discrete 
voids spaces created by the dynamic redistribution of solvent molecules and assumes the 
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redistribution can occur with no change in free energy [47].  Hydrodynamic theory is 
based on Stokes-Einstein equation for solute diffusivity, wherein the solute is treated as a 
hard sphere.  Mathematically the model is the ratio of the thermal energy divided by a 
frictional drag coefficient [48].  Obstruction theories treat the polymer as impenetrable 
chains effecting tortuosity of the diffusion path.  Improvements to this theory include 
models using distributive probability functions describing the probability of a solute 
passing through a space in the polymer mesh [49, 50].  Application of transport models to 
bio-responsive hydrogels will depend on solute-polymer interactions and polymer 
morphology.  Table 1 lists models which can be applied to various morphologies.  
Table 1:  Diffusive transport theories as they apply to hydrogel morphology. 
Theory Hydrogel Morphology Equation  Ref 
Free Volume Porous   = ∗	
  (1) [46, 51, 52]  
Free Volume 
Nonporous, Highly 
Swollen 
 =  
 −∗ −∗exp
− − 1 (2) [46, 52, 53] 
Hydrodynamic Micro-Porous 
 = 1 − 1 + ! + "#
+ $% 
(3) [46, 52, 54]  
Obstruction Porous   = &&' () (4) [46, 52, 55] 
 
Where Dip is the diffusion coefficient of species i in the polymer matrix; Db is the 
diffusion coefficient of the solute through the bulk;  Diw diffusion coefficient of species i 
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in the solvent; λ* is the diffusional jump length of the solute; υ is the jump frequency;  
is the average molecular weight between crosslinks;  is the average molecular weight 
of the polymer without crosslinks; ∗ is the critical molecular weight between crosslinks; 
λ is the ratio of the solute radius to the average pore radius; α, β, and γ are constant 
dependent on the system; Kp is the partitioning coefficient; and Kr is the fractional 
reduction in diffusivity as the solute diameter approaches the pore diameter. 
A separate but equally important consideration to modeling solute transport in 
hydrogels is the constitutive equation which will be applied to match the release profile.  
Many approaches have been taken based on empirical and semi-empirical models.  These 
models offer relatively high predictability of solute transport without requiring intricate 
knowledge of the polymer-solute interactions and mathematically are relatively simple.  
Table 2 lists several of these models. 
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Table 2:  Empirical and Semi-empirical models for solute diffusion in hydrogels. 
Model Equation   Special Constraints Ref 
Hixson Crowell Cube Root *+/#	 −*./# = / (6) 
 
[56] 
Korsemeyer-Peppas 
.0 = / (7)  
[56] 
First-Order ln 3+.4 = / (8)  
[56] 
Zero-Order Kinetic Model + −. = / (9) 
 
[56] 
Peppas Anomalous Transport 
.0 = / + //	 10	  6 > 0.5 [57] 
 
Where k, k1, k2, n, and A are constants dependent on the system; Mi is the solute 
concentration at a given time, t; Wi is the weight of the solute at a given time, t; D is the 
diffusivity coefficient; and L is slab thickness. 
Equation (7) allows solute transport to be determined as less Fickian, Fickian, or 
anomalous transport based on the experimentally determined value of n: n < ½ in less 
Fickian, n = ½ in Fickian, and n > ½ for anomalous transport.  Fickian or less Fickian 
transport indicates water penetration rate is less than the polymer chain relaxation rate.  
Anomalous transport indicates water penetration rate occurs faster than the hydrogel 
relaxation rate.  Constants k1 and k2 in Equation (10) describe the rate of relaxation 
controlled transport and the rate of diffusion controlled transport [58], respectively. In the 
application of these models it is common to utilize the model which yields the greatest 
least-squared regression is used to determine the most applicable model. 
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The need for more accurate predictions based on system parameters, specifically 
geometry and solubility state, in diffusion limited drug delivery systems has led to the 
development of explicitly derived release equations.  Equations for slab, cylindrical, and 
spherical geometries have been developed for non-constant activity release sources, 
where the drug is completely separate from the releasing membrane (shell-core-structure) 
and below its solubility limit; constant activity release sources, where the drug is 
completely separate from the releasing membrane (shell-core-structure) but above its 
solubility limit; monolithic release solutions, where the drug is homogenously distributed 
within the releasing material and below its solubility limit; and monolithic release 
dispersions, where the drug is homogenously distributed within the releasing material but 
above its solubility limit [59].  The derived equations and simplified approximations are 
presented in Table 3.  For the complete, explicitly derived equations, detailed summary of 
the applications, assumptions, and special cases, such as lag-time or burst phase, the 
reader is directed to the literature [45, 59]. 
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Table 3: Explicitly derived equations and time approximations for diffusive transport of 
species from hydrogel [59]. 
Source Type Geometry Equation  Special Constraints 
Non-Constant Activity Source 
Slab 
.0 = 1 − exp 3−
:&/;< 4 (11) 
 
Cylinder 
.0 = 1 − exp−
=> + =+> + 2==+&/=>=+ − =  (12)  
Sphere . = 2@>&Aln	=B =	⁄ / (13)  
Constant Activity Source 
Slab . = :&A< / (14)  
Cylinder . = 4@&A=+==+ − = / (15)  
Sphere . = 2@>&Aln	=B =	⁄ / (16)  
Monolithic Solution 
Slab 
.0 = 43
/@<4
/
 (17) 
Early times 
. 0 ≤ 0.6⁄  
.0 = 1 −
8@ exp−@
/<  (18) 
Late times 
. 0 ≥ 0.4⁄  
Cylinder 
.0 = 43
/@=4
/ − /= (19) 
Early times 
. 0 ≤ 0.6⁄  
.0 = 1 −
42.405 exp−2.405
/=  (20) 
Late times 
. 0 ≥ 0.4⁄  
Sphere 
.0 = 63
/@=4
/ − /= (21) 
Early times 
. 0 ≤ 0.6⁄  
.0 = 1 −
6@ exp−@
/=  (22) 
Late times 
. 0 ≥ 0.4⁄  
Monolithic Dispersion 
Slab . = :IA2A − A/ (23) 
 
Cylinder 
.0 −
32 K1 − 31 − .04
 #⁄ 	L = − 3A=A / (24)  
Sphere 
.0 + 31 −
.04 ln M1 −
.0N =
4A=A. /	 (25)  
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Where Mt and M∞ is the cumulative amount of drug released at time t and ∞, respectively; 
A is the total surface area normal to the diffusive release path; D is the diffusion 
coefficient of the solute; K is the partitioning coefficient of the solute between the 
membrane and the reservoir; V is volume of the reservoir; L is the membrane thickness; 
Ri and R0 are the inner and outer radius, respectively, of the cylinder or sphere membrane; 
H is the cylinder length; R is radius of the cylinder or sphere; Cs is drug solubility in the 
reservoir or wetted matrix for constant activity or monolithic dispersion source types, 
respectively; and Cint is the initial loading concentration. 
Convective transport is caused by external velocity gradients or by equilibrium 
changes which cause water to move in or out of the hydrogel.  In both cases, species 
solvated by water will be subject to convective transport.  This type of transport is best 
exemplified by super-porous hydrogels (SPHs), hydrogels with pore sizes in the several 
hundred micrometer range; such SPHs rapidly imbibe water via capillary forces [60].  In 
addition to convective transport, transport due to electrical gradients is usually coupled 
with other thermodynamic phenomena such as: swelling, deswelling, or erosion [61]. The 
interaction of three potential fields, chemical, electrical and mechanical, must be 
considered when modeling transport within hydrogels. Wallmersperger et al., describes 
methodologies for modeling such systems [62]. 
Understanding transport in bioresponsive hydrogels empowers predictive 
coupling with kinetic and thermodynamic phenomena to engineer more complex systems.  
Various theoretical and empirical models can be used, but care must be taken in the 
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selection of the appropriate equations to accurately predict transport and its relation on 
other fundamental phenomena. 
1.2.2.3. Governing Phenomena – Thermodynamics 
Thermodynamic equilibrium plays a principal role in the design of bioresponsive 
hydrogels.  While coupled mass transport and biorecognition reaction kinetics guide 
temporal processes, thermodynamics govern direction of change and final state of the 
system. Here, two thermodynamic phenomena, polymer solvation theory and chemical 
equilibrium theory, will be considered. 
Polymer solvation theory originated with the lattice based Flory-Huggins (1942) 
theory which sums the free energy of mixing of network chain elements and solvent, 
ΔPQR, electro-osmotic pressure within the network due to mobile couterions, ΔPB, and 
elastic retractile force of the polymer network,	ΔPSTU [63-66], Equation (26), and its 
subsequent derivation results in Equation (27) 
ΔPQR + ΔPSTU + ΔPB = −VW∆YWZ [\,^ = 0   (26) 
@QR = − _\Z` ab61 − c + c + dce (27) 
Where V1 is the molar volume of the solvent, pimix is the osmotic pressure of the polymer 
solution, ν is the polymer volume fraction, and χ represents the change in the interaction 
energy upon the mixing of the polymer and solvent.  Low values of χ is associated with 
high polymer-solvent intercations and low hydrophobic interactions, which are indicative 
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of highly hydrophilic polymers [67].  χ may be readily calculated for hydrogels using 
Equation (28) [68, 69]. 
χ = − ghij	kj	klmn`oj	
p`ij	qr`s
j		                 (28)                   
Where υe is the effective crosslink density, φ2 is the polymer volume fraction, and f is the 
functionality of the crosslinker.  Extensions of Flory-Huggins theory lead to models 
which predict lower critical solution temperature [70, 71], a critical parameter for 
temperature responsive hydrogel.  Further modification of the theory by Peppas and 
Merrill accounts for hydrogels prepared in solvent, water, by considering the volume 
fraction density of chains during crosslinking in a neutral hydrogel and results in a 
relation to determine molecular weight between crosslinks  Equation (29) [72]. 

t u = t v −
(l n`)⁄ wghxil	,yzkl	,yk{`l	,y	 |
l	,}K3~	,y~	,}4
`/pi3 ~	,y	~	,}4L
                      (29)  
Where  is the molecular weight of the polymer chains absent of the crosslinking agent, 
̅ is the specific volume of the polymer, V1 is the molar volume of the water, υ2,r is the 
polymer volume fraction immediately after crosslinking (relaxed state), and υ2,s is the 
polymer volume fraction in the swollen state.  Determination of  allows for the 
calculation of the linear distance between adjacent crosslinks, ξ, which is considered the 
pore or mesh size.  ξ provides valuable insight into polymer morphology and can be 
readily applied to transport models which predict diffusivity constants [50].  Calculation 
of ξ can be made by combination of Equations (29) and (30). 
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ξ = υ,i/# Vvt ut} [
/ l                                              (30)  
Where Cn is the Flory characteristic ratio, Mr is the molecular weight of repeat unit, and l 
is the bond length along the polymer backbone.  Determination of  can also be 
performed through mechanical methods relating applied stress or modulus to  by 
extentions of rubber elasticity theory [72, 73]. 
Cationic and anionic hydrogels are readily extended as bioresponsive hydrogels 
by the incorporation of enzymes which create localized changes in pH through catalysis 
subsequently changing the thermodynamic state of the polymer [74, 75].  They have also 
been used in applications where biological changes in pH actuate a response[76]. 
Swelling relations for cationic and anionic polymers prepared in the presence of solvent 
have been derived, Equations (31) and (32), respectively. 
;1
4 Vc2,
2
c [ V &1014−>−&[
2 = wlnx1 − c2,z + c2, + d1c2,2 | + V ;1c[ V1 − 2

6 [ c2, MVc2,c2,[
1/3 − Vc2,c2,[N  (31) 
;1
4 Vc2,
2
c [ V &10−>−&[
2 = wlnx1 − c2,z + c2, + d1c2,2 | + V ;1c[ V1 − 2

6 [ c2, MVc2,c2,[
1/3 − Vc2,c2,[N     (32) 
Where I is ionic strength and Ka and Kb are the acid and base dissociation constants, 
respectively [52]. 
Reaction equilibrium in bioresponsive hydrogels can be determined by 
fundamental Equations (33) and (34) [77].   Generally, reaction equilibrium can be 
considered less important than reaction kinetics.  In catalyzed reactions, the reaction 
occurs quickly relative to other phenomena occurring in the system, e.g. polymer 
swelling or mass transport. Therefore, pseudo equilibrium is usually a reasonable 
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assumption for the catalyzed reaction unless the system is designed to negate rate limiting 
phenomena.  In binding reactions, the equilibrium lies far to the right so it can be 
assumed that all free species will be bound until the binding sites become saturated.  
While these assumptions are generally true, reaction equilibrium has been leveraged to 
engineer novel systems.  In one example, an enzyme which normally hydrolyzes peptide 
bonds is used in the self-assembly of nanofibrous peptide structures by reversing the 
normal reaction direction [78]. 
A +  B ⇌  C +  D (33) 
K = u///  (34) 
1.3. Response Types  
1.3.1 Swelling or Collapse - pH and Ionic Actuation 
Hydrogels are 3D cross linked networks of highly hydrophilic monomer 
containing moieties such as ethers, thiols or hydroxyls and ionizable groups such as 
carboxyls and amines. The latter groups have individual pKa values which, depending on 
monomer composition and dissociation strength, will produce a net charge on the 
hydrogel. Net charge neutrality is maintained by balancing the hydrogel charge with 
counterions drawn from the solution. The increased concentration of ions leads to an 
electroosmotic pressure as well as a space charge layer that extends into the diffusion 
layer in solution. A hydrogel in solution will thus reach an equilibrium swelling point 
where the osmotic pressure force, which drives water into the hydrogel, is balanced by 
18 
 
the mechanical retractile forces of the chemical bonds holding the matrix together. This 
balancing of osmotic and mechanical forces in a hydrogel matrix is similar to the 
deformation of a spring to which a force is applied [79-81].   
Changes in internal charge balance actuate swelling or collapse of hydrogels.  
Changes in solution pH or ion concentration (dielectric constant) can force the solution 
and hydrogel away from equilibrium. To restore equilibrium, protons or other ions will 
diffuse into or out of the hydrogel restoring net charge neutrality. Mechano-osmotic 
equilibrium is reestablished by the transport of water into or out of the hydrogel. This 
process has been modeled using a FEM approaches which combines transport, Equation 
(35), electrostatics, Equations (36-37), and mechanical deformation, Equations (38-41) 
[82, 83].   

 + ∇ ∙ x−D¢qq,£∇C£ − z£u¦,£FC£∇ Vz = R£              (35) 
Where Equation (35) is the Nernst-Planck equation with C as concentration of species i, 
Deff is the effective diffusivity, z is the ion valence, um is the ion mobility, F is Faraday’s 
constant, V is potential, and R is a reaction term.   
∇ ∙ (−ϵ+ϵ«∇V) = F(z¬­C¬­ + z®rC®r)    (36) 
3¯­¯­° 4
`
±²¯­± = V¯r°¯r[
`
±²¯­± = λ (37) 
Electrostatic migration can be coupled to transport by Equation (36) which combines the 
Helmholtz and Gauss laws relating charge density to potential. Where ε0 and εr are the 
vacuum and relative permittivities of the ion, respectively.  Alternatively, Donnan 
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potential has been used to calculate ion concentrations; where Ck+, Ck+0 and positive ion 
concentrations inside and outside the gel and Ck- and Ck-0 are negative ion concentrations 
inside and outside the gel, respectively. Donnan potential assumes the partitioning ratio, 
λ, to be constant and Equation (37) is not used contribute to temporal electro-migratory 
transport.  This approach can be taken to reduce computational expense [84].    
σ£¶ = E£¶¸gxu¸,g − (εº)¸gz  (38) 
ϵº = k(∆π − ∆π+) (39)   
∆π = RT ∑ xC¿ − C¿«¢qzÀÁ¿Â  (40) 
Ã Ä = σ£¶,¶ + ρb£ (41) 
Mechanical stress-strain deformations have been coupled temporal concentration changes 
via osmotic pressure; where σ is the stress tensor; E is the elasticity tensor; u is the 
geometric strain; εpi is the swelling strain; k is the swelling coefficient; pi and pi0 are the 
osmotic and initial differential osmotic pressures, respectively; R is the ideal gas 
constant; T is temperature; Cα and Cαref are the concentrations and reference concentration 
at the gel-solution boundary, respectively; f is the mechanical damping parameter; ρ is the 
mass density; and b is the volume forces.    
In one such model the reversible swelling and collapse of a pH responsive 
chitosan hydrogel was explored through FEM and compared to experimental results for a 
pH range between 5.0 and 8.5, Figure 3 [84, 85]. While models for swelling and collapse 
have been successfully demonstrated experimentally, using a FEM approach to model pH 
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or ion actuated drug release is largely unexplored in the literature and is an ongoing area 
of research. 
Figure 3:  Comparison of experimental to theoretical results for a pH responsive chitosan 
hydrogel from a FEM approach. 
 Others have used bioresponsive hydrogels in biosensors and as stimuli responsive 
drug delivery vehicles [76]. In one construct, a pH responsive polymer, poly(2-
vinylpyridine-co-divinylbenzene), was conjugated to gold nanoparticles containing 
magnetic iron oxide (IONPs) and fluorescent CDSe/ZnS quantum dots (QD). This 
construct allowed for a multi-responsive system wherein the pH responsive polymer 
enabled size control, the IONPs enabled manipulation via magnetic fields, and the QDs 
enabled fluorescence detection [86].  In other work, the activity of molecularly imprinted 
polymers (MIPs) has been tuned via the addition of a pH responsive polymer to the 
construct. MIPs designed to mimic the active sites of enzymes are typically more stable 
than their biological equivalents but often lack the binding. A MIP which mimics the 
catalytic ability of a peroxidase was conjugated with pH responsive polymers to form 
nanospheres wherein the catalytic ability of the nanospheres was shown to be a function 
of pH and had an optimum pH of 8.3 [87]. 
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1.3.2 Erosion and Degradation 
Another response that has been leveraged in the application of bioresponsive 
hydrogels is the degradation or erosion of the polymer matrix in response to a 
biomediated stimulus. For this discussion degradation will be considered the breakdown 
of the polymer matrix into monomeric constituents which were originally polymerized to 
create the matrix, and erosion is breakdown of the polymer matrix into smaller 
oligomeric chains wherein some polymeric constituents remain intact.  
Eroding hydrogels have found wide acceptance in tissue engineering and drug 
delivery applications. At the root of the erosion process is the hydrolysis of a labile bond 
that is part of the hydrogel backbone and/or crosslinks.  Commonly, this is the hydrolysis 
of an ester bond, as in poly(lactic acid) (PLA) or poly(lactic-co-glycolic acid) (PLGA); 
however, the hydrolysis of an anhydride or anhydride-co-imide bond, as in poly(sebacic 
acid) or poly-[trimellitylimidoglycinr-co-bis (carboxyphenoxy) hexane)], has been 
demonstrated [88-90]. Erosion rates in thermoplastics can be controlled by chemical 
composition and processing methodologies which can alter crystalline and amorphous 
regions in the material.  Additionally, the polymer can be surface or bulk eroding where 
the water penetration rate is slower than the erosion rate or vice versa. Eroding hydrogels 
are becoming more widely used as their mechanical integrity is improved, tuneability of 
their thermal responsiveness is more easily accomplished, processability difficulties are 
addressed, and polymers with cytotoxic pH byproducts from erosion have been replaced 
by polymers with neutral pH byproducts.  Specifically, the poly(ortho ester) IV family 
has addressed most of these problems and is being developed commercially [88, 91]. 
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Alternative to erosion, degradation involves breakdown of the polymer matrix 
into monomer and smaller oligomeric chains. Nonspecific degradation can occur via a 
hydrolytically unstable bond within the matrix or may occur enzymatically wherein 
esterases or peptidases  cleave ester or amide bonds, respectively [11, 92].  Enzymatically 
triggered degradation in drug delivery and tissue engineering allows for targeted, 
controlled degradation of the polymer.  The triggered degradation of the polymer matrix 
is advantageous because the matrix can remain in its native state until it is exposed to a 
specific enzyme.  Degradation rates can be controlled by varying concentrations of the 
enzymatically cleavable crosslinking substrate, altering the sequence to increase or 
decrease its enzymatic affinity or reactivity, or altering the morphology of the hydrogel 
matrix effecting enzyme access [93, 94]. In one construct, an in situ gelating, enzyme 
degradable hydrogel was synthesized for soft tissue augmentation wherein the gel could 
be injected post-surgery to act as a synthetic scaffold for cellular proliferation.   This gel 
was able to polymerize without the use of potentially cytotoxic free-radical initiators, a 
major concern for injectable hydrogels.  Additionally, a cellular adhesion peptide was 
attached as a pendant group to promote receptor mediated cellular attachment. A 
collagenase cleavable peptide was integrated into the hydrogel backbone to support 
enzyme mediated degradation, Figure 4 [95]. In another example, a hydrogel matrix was 
synthesized that was susceptible to degradation by matrix metalloproteases (MMPs). The 
dextran based hydrogel was cross-linked with a MMP-cleavable peptide motif via 
maleimide functional groups [31]. MMP mediated degradation of hydrogel matrices is an 
23 
 
ongoing area of interest as these enzymes are an integral part of tissue reconstruction 
[96]. 
Figure 4:  A bioresponsive hydrogel which gels in situ and degrades when exposed to 
collagenase [95]. 
1.3.3 Release 
Bioresponsive hydrogels have been used extensively as vehicles for the delivery 
of therapeutic molecules.  It is common to use a biological stimuli such as pH [97], redox 
potential [98], activity of biomacromolecules [11] or concentration of metabolites [34] to 
trigger release from the hydrogel.  Other stimuli such as temperature [99], ultrasound 
[100], light [101], and magnetic fields [102] have been used to trigger release of drugs; 
however, these are considered environmental stimuli and therefore are outside the scope 
of this discussion. Using bioresponsive hydrogels as triggered release vehicles allows for 
tighter control over the amount of drug being delivered, the rate at which it is 
administers, and can reduce unwanted side effects to ancillary systems because the drug 
is localized only to desired regions and release is motivated by the activity of a 
biomarker. The mechanism for release can occur through physical changes to the 
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hydrogel matrix such as erosion, degradation, swelling, collapse, or through enzymatic 
cleavage. 
An application of controlled release was demonstrated through the creation of a 
hydrogel-enzyme construct which mimicked the role of the pancreas by releasing insulin 
upon exposure to glucose. The hydrogel, possessing a pH responsive pendant amine, 
dimethylaminoethyl methacrylate (DMAEMA, pKa = 7.5), was co-loaded with glucose 
oxidase (GOx) and insulin.  Upon exposure to glucose, GOx oxidized the glucose 
creating hydrogen peroxide and gluconic acid. The gluconic acid reduced the local pH 
within the hydrogel causing protonation of the DMAEMA and promoting electro-osmotic 
swelling thereby increasing the effective diffusivity of insulin within the matrix and 
promoting its release. The authors were also able to demonstrate zero-order release 
behavior by non-uniform loading of insulin within the hydrogel matrix [3].  In other 
work, the mechanism of loading through covalent attachment and the control of release 
rate were explored. The authors stoichiometrically controlled the loading of a peptide-
linked chromogen by varying the mole fraction of the pendant, conjugatable amine group 
of co-polymerized aminoethylmethacrylate (AMEA). Release of the chromophore was 
mediated by exposure to chymotrypsin which cleaved the covalently attached peptide. 
The release rate was controlled by changing the cross-linker concentration, and in effect, 
the apparent diffusivity of chymotrypsin [103]. 
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1.3.4 Mechanical  
1.3.4.1 Gelation 
In situ gelation has become an emerging trend in the application and research of 
bioresponsive hydrogels. Hydrogels that can cross-link in vivo following injection are 
desirable because they can be implanted as solutions using a syringe and so they can 
negotiate close-fitting tissue-to-gel contact in comparison to precast hydrogels. Physically 
crosslinking and photo-crosslinking approaches have been demonstrated; however, they 
have drawbacks such as low mechanical strength and the need for cytotoxic photo-
initiators, respectively. An alternative approach being explored is enzyme mediated 
cross-linking of hydrogels [30, 104]. The gelation of such hydrogels occurs by the linking 
of pendant groups through enzymatic catalysis.  In situ cross-linking of phenol moieties 
which were attached to a dextran-tyramine (Dex-TA) based hydrogel has been 
demonstrated.  The cross-linking was mediated by horseradish peroxidase (HRP) and 
degradation of the hydrogel was realized through hydrolysis of the ester bonds.  Gelation 
rate was shown to be dependent on HRP/TA ratio [30].  For further discussion of in situ 
hydrogel formation the reader is directed to Van Tomme [105]. 
1.3.4.2 Shape Transformation 
The shape of a hydrogel construct is known to effect drug carrier performance 
[106]. Engineering the ability to biologically trigger a shape change of a bioresponsive 
hydrogel is of growing interest. As an example, spherical and elliptical hydrogels 
experience different hydrodynamic forces as they move through the vasculature. 
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Additionally, elliptical hydrogels have been shown to avoid phagocytosis more readily 
than spherical hydrogels. While elliptical hydrogels are not phagocytosed as readily, they 
also do not undergo endocytosis at the targeted cell as readily as spherical gels. This 
makes it desirable to have an elliptical hydrogel in the vasculature, and then have a 
spherical hydrogel near the delivery site [107].  To this end, a bioresponsive hydrogel 
which can change shape upon a tissue specific stimulus are being explored. In one 
construct a shape transformational hydrogel was created which changes from elliptical to 
spherical orientation in response to pH, temperature and an analyte.  The shape change is 
driven by the balance of interfacial tension and polymer viscosity, Figure 5 [108]. 
Figure 5: Temperature, pH, and chemically responsive hydrogel which changes shape 
from an elliptical to a spherical configuration based on environmental conditions [108]. 
1.3.5 Optical 
Bioresponsive hydrogels that exhibit an optical response to a stimulus are gaining 
traction as a viable platform for biodetection and biosensing. The mechanism for 
detection or sensing may result from swelling or collapse of the hydrogel matrix that 
changes the shape of a lens [109], changes the refractive index[110], gelation [111], 
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turbidity, or induces a change in absorption or an emission [112]. In each case the change 
in the hydrogel matrix causes a detectable or measurable optical response. Additionally, 
chromophores or fluorophores may be released pursuant to binding or become activated 
by catalysis [1, 4, 113]. Responses can be visible by the naked eye or may require 
measurements of absorbance or emission at specific wavelengths [17, 111]. In a more 
recently developed system, thioglycolic-acid-capped quantum dots (CdSe QDs) were 
covalently attached to an acrylamide based hydrogel microspheres that were cross-linked 
with DNA motifs. When exposed to the complimentary strand of targeted DNA, the 
binding of the DNA strands resulted in hydrogel collapse due to the uptake of 
counterions.  The collapsing event resulted in a blue shift in the Bragg diffraction peak.  
This system proved to be highly sensitive, down to 1 nM, and could differentiate DNA 
sequences that differed by one base pair, Figure 6 [114].  
 
Figure 6:  DNA sensing bioresponsive, quantum dot loaded hydrogel which elicits a shift 
in its peak absorbance upon exposure to the complimentary target DNA [114].  
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1.3.6 Electrochemical 
 Due to their high biocompatibility, hydrogels have been widely used in 
biosensors, both as an interface between tissue and electrode and also as a host for 
bioactive molecules[115].  By incorporating oxidoreductase enzymes into the polymer 
matrix, the biospecificity of the enzyme is conferred to the transducer and the enzyme 
stabilized in a hydrated 3-D milieu[116]. In amperometric, biosensors the electrodes act 
as an eventual source or sink for the electrons being transferred by the enzyme.  
Biosensors which measure analyte concentrations have been designed based on other 
electrical properties such as potential or impedance [18]. To increase sensitivity, reduce 
interfacial impedance, reduce interference from endogenous and exogenous species, and 
improve biocompatibility, electroconductive polymers such as polyaniline, polythiophene 
and polypyrrole, have been synthesized into the voids of the hydrogel matrix [18]. The 
resulting electroconductive polymer hydrogel composites also show the potential for 
programmed release of loaded drugs under modest voltage stimulation. Another approach 
to facilitate electron transfer in biosensors is the conjugation of the redox enzyme to 
single-walled carbon nanotubes (SWNT). Enzyme-SWNT conjugates have been shown 
to increase the peak current; additionally, graphene based biosensors are also being 
developed based on similar principles[117, 118] and may be incorporated into hydrogels. 
These composite materials add new response modes to the bioresponsive hydrogels.  
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1.4. Remarks and Conclusions 
Bioresponsive hydrogels are increasingly being studied because they are highly 
biospecific, and they exhibit controlled response readily co-joined with biomolecular 
recognition. Moreover, there are many technological opportunities in targeted drug 
delivery, biosensors and regenerative medicine that motivate continued energetic pursuit 
of devices based on bioresponsive hydrogels. The design challenge is in effectively 
linking the conferred biospecificity with an engineered response tailored to the needs of a 
particular application. Moreover, the fundamental phenomena governing the response 
must support an appropriate dynamic range and limit of detection. The design of these 
systems is inherently complicated due to the high interdependency of the governing 
phenomena that guide the sensing, transduction, and the actuation response of hydrogels.  
While the dynamics between these phenomena are continually being investigated, 
bioresponsive hydrogels can still be designed using current theoretical models along with 
experimentally determined properties.  The application of bioresponsive hydrogels is 
wide ranging, and they have been developed into tissue engineering constructs, 
biosensors, and targeted drug delivery vehicles.  Future developments will of necessity 
contain control loops similar to synthetic metabolic pathways.  The use of these materials 
will continue to expand as they become coupled and integrated with new technologies.  
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CHAPTER 2:  BIOACTIVE HYDROGELS DEMONSTRATE 
MEDIATED RELEASE OF A CHROMOPHORE BY 
CHYMOTRYPSIN 
2.1.  Introduction 
A major challenge faced in drug delivery is administering a drug to a specific 
location at a controlled rate and amount. This is particularly challenging when the release 
rate and amount, must be controlled to a physiologically derived stimuli – so called bio-
responsive drug delivery. To meet this challenge, biologically responsive hydrogels are 
being investigated as drug delivery vehicles [93, 119]. Since hydrogels can be tuned to be 
stimuli responsive and stimuli specific, they are attractive drug delivery systems because 
they can be tuned to deliver therapeutic molecules in a sustained or bolus type release 
[120], and do so in response to a biologically derived stimuli [121, 122]. Environmental 
[123], temperature [124] and pH-responsive hydrogels [75] have been designed by 
controlling solubility and ionic characteristics, and they have been successfully 
implemented in commercial applications [2, 125]. To increase the specificity of 
responsive hydrogels, bio-specific recognition agents have been combined with 
responsive hydrogels to create systems which sense and respond according to an 
engineered input[11, 38, 126-129]. Specifically, peptide sequences [130, 131] and 
enzymes have been used to provide biorecognition specificity[132]. Enzyme distributions 
may differ largely between healthy and diseased cells or biological systems [133, 134], 
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and this accordingly allows for the use of enzyme responsive hydrogels in disease 
targeting [2]. 
There are many possible designs of hydrogel drug delivery systems [11, 135, 
136], and these are dictated by the specifics of the application. While not all hydrogel 
drug delivery systems can be improved by incorporating a bio-responsive component into 
the delivery scheme, cases do exist where vast improvements can be made. One such 
instance is the delivery of nerve growth factors (NGF).  In work by Jhaveri et al. [137], 
poly(HEMA)-based hydrogels were loaded with NGFs by physical entrapment and 
subsequently released to promote neural growth around the hydrogel implant[137]. An 
improvement to this system would be the release of the growth factor triggered by 
cellular activity rather than the diffusivity rate of the entrapped NGF.  This would enable 
the drug delivery rate to be mediated by biological (cellular) activity instead of by 
transport properties. Other studies have used Chondroitinase ABS, which degrades 
known neural growth inhibitors, to promote spinal cord recovery. Combining this enzyme 
with macroporous poly(HEMA)-based scaffolds used in spinal cord tissue engineering 
could improve the efficacy of such a system through release that was controlled by 
enzyme activity [138, 139].  Delivery systems may utilize different immobilization 
techniques, triggering mechanisms, and degradability. In previous work, we physically 
co-entrapped insulin and glucose oxidase (GOx) within poly(HEMA)-based hydrogel 
beads that included co-polymerized pH-responsive dimethylaminoethylmethacrylate 
(DMAEMA) monomer[3]. This molecularly engineered system clearly demonstrated 
programmed release of insulin mediated by the diffusion of glucose into the hydrogel. In 
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this system, the diffusing glucose was converted to gluconic acid via reaction with GOx. 
This caused an internal pH decrease that resulted in increased protonation of the tertiary 
amine, increased swelling of the hydrogel, and consequently, increased diffusivity of the 
peptide insulin out of the hydrogel; but not of GOx. The rate of insulin release could then 
be controlled by the bathing concentration of glucose.  
To better understand the fundamental factors that control the release rate of a 
cleavable molecule from within a swellable hydrogel, a model system employing 
chymotrypsin as a surrogate for proteases and an enzyme cleavable chromogen, N-
succinyl-Ala-Ala-Pro-Phe p-nitroanilide (Suc-AAPF-pNa) [140], was investigated. The 
hydrogel was a non-biodegradable, poly(HEMA)-based hydrogel that contained varying 
amounts of 2-aminoethyl methacrylate (AEMA) and was of variable cross-link density 
[141]. To study the release characteristics of this system, the release of the p-nitroanilide 
(pNa) chromophore was measured colorimetrically after the peptide sequence AAPF was 
cleaved by externally derived chymotrypsin. Cleavage causes the release of pNa and its 
subsequent colorimetric activation.  To understand the influence of substrate loading by 
covalent conjugation, the AEMA content of the hydrogels was systematically varied.  
AEMA has a terminal primary amine group which is available for covalent conjugation 
with the chromogen. Varying the amount of primary amine groups within the hydrogel 
will therefore determine the amount of chromogen that can be covalently conjugated 
within the hydrogel.  To understand the role of enzyme kinetics and/or mass transport 
effects as governing phenomena for the release rate, the cross-linked density of the 
hydrogel was likewise systematically varied. By systematically varying the cross-linker 
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concentration, the available void volume for transport is changed, and the effect this 
change has on the transport of the enzyme into the hydrogel can be studied. Following 
cleavage and release, the release rates were used to determine the Thiele moduli, which 
provided a novel approach to analyzing and optimizing the interactions of stimuli–
causing enzymes within bio-responsive hydrogels. Through analysis of the determined 
Thiele moduli, the rate limiting process can be identified [142-144].  If mass transport 
limitations are governing the release, system parameters, specifically cross-linked density 
or the characteristic dimension, can be altered to avoid the limiting effects of mass 
transport which optimizes the release system. 
2.2.  Material and Methods 
2.2.1 Hydrogel Disk Formulation and Characterization 
The hydrogel components 2-hydroxyethylmethacrylate (HEMA), the divalent 
cross linker, tetraethyleneglycol diacrylate (TEGDA, technical grade), N-
[tris(hydroxymethyl)methyl]-acrylamide (HMMA, 93%), poly(N-vinylpyrrolidone) 
(pNVP,MW=1,300,000), 2-aminoethyl methacrylate (AEMA), and the photoinitiator 2,2-
dimethoxy-2-phenylacetophenone (DMPA, 99%) were purchased form Sigma Aldrich 
(Milwaukee, Wisconsin, USA).  Prior to formulation, all of the liquid methacrylate and/or 
acrylate-containing reagents were passed over an inhibitor removal column (Sigma-
Aldrich) to remove the polymerization inhibitors hydroquinone and/or monomethyl ether 
hydroquinone. Tris(hydroxymethyl)aminomethane (TRIS buffer, ACS reagent, 99.8+%,) 
was pH-adjusted with hydrochloric acid (ACS reagent, 37%) to obtain 0.1 M buffer of 
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pH = 7.4. Phosphate buffered saline (PBS) (1X, pH7.1) and 2-(N-morpholino) 
ethanesulfonic acid (MES Buffer, pH 4.7) were used.  The peptide substrate, N-succinyl-
Ala-Ala-Pro-Phe p-nitroanilide (CAS# 70967-97-4), and the enzyme, chymotrypsin (EC# 
3.4.21.1), were purchased from Sigma–Aldrich (Milwaukee, Wisconsin, USA).  Coupling 
reagents 1-ethyl-3-[3-dimethylaminopropyl] carbodiimide hydrochloride (EDC) and N-
hydroxysulfosuccinimide sodium salt (Sulfo-NHS) were purchased from Thermo 
Scientific (Rockford, Illinois) and Sigma-Aldrich (Milwaukee, Wisconsin, USA), 
respectively. All solutions were prepared with deionized (MilliQ DI) water.  
Bioactive p(HEMA)-based hydrogel pre-polymer cocktails were formulated by 
mixing the six constituents HEMA, TEGDA, HMMA, pNVP, DMPA, and AEMA with 
molar percentages outlined in Table 4 [145, 146]. HEMA was the primary monomer 
constituent and was chosen for its high hydration, non-biofouling, non-biodegradable 
characteristics.  TEGDA was an effective cross linker that controlled the internal void 
volume. HMMA was used to increase hydrophilicity and hydration.  pNVP was used to 
increase the viscosity of the monomer solution. DMPA was the photointiator for UV 
initiated polymerization of and acrylate and methacrylate groups.  AEMA provided a 
reactive primary amine for covalent conjugation.  Two sets of hydrogels were 
formulated; the first set  varied AEMA mol% (Study A) and the second of varied 
TEDGA mol% (Study B).  Gel formulations are summarized in Table 1.   
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Table 4:  Hydrogel compositions for Studies A and B. 
                      
The pre-polymer mixtures were added to a 1:1 (v/v) solution of ethylene 
glycol/water to improve monomer solubility.  The ethylene glycol/water mixed solvent 
was a total of 20 wt% of the final formulation. The solutions were mixed until all 
monomers had been dissolved and then sparged with nitrogen. An aliquot of 30 
microliters of each hydrogel cocktail were evenly applied to silicone isolators, Figure 1, 
(664206, Grace Biolabs) of thickness 2.0 mm and diameter 4.5 mm. The mixtures were 
immediately UV irradiated (366 nm, 2.3 watts/cm2, 5-7 min) in a UV cross-linker (CX-
2000, UVP, Upland, CA, USA) under a flowing inert nitrogen atmosphere to effect 
polymerization of hydrogel discs. The resulting hydrogel discs were removed from the 
mold then simultaneously hydrated and solvent extracted.  Hydration and solvent 
extraction was performed by sequential immersion in ethanol:PBS mixtures (75:25; 50:50 
v/v) for a minimum of 1 h each and finally transferred to 100% PBS buffer.  Sequential 
dilutions of ethanol were used to reduce the strain on the hydrogel disks which can lead 
to their cracking if the disks are placed directly into buffer.  This procedure removed un-
36 
 
reacted monomer that was not polymerized into the hydrogel backbone during 
polymerization, and it also replaced any residual ethylene glycol/water solvent with 
buffer. 
Figure 7:  Silicone Isolator (Left), Hydrated 5% TEGDA/30% AEMA Hydrogel from 
Study B diameter (Center) and thickness (Right) dimensions. 
The hydrated dimensions and void fractions of the hydrogels in Study B were 
experimentally determined.  The physical dimensions of the hydrated gels were obtained 
by determining the hydrogel disk thickness and diameter using photographic dimensional 
analysis with ImageJ Software, Figure 7.  Disk volume was calculated with diameter and 
thickness values by assuming cylindrical geometry.  The masses of the hydrated and 
dehydrated gels were determined gravimetrically. The hydrogel discs were dehydrated 
(dried) in a Caliper-Zymark TurboVap 500 (Caliper Life Sciences, Hopkinton, MA, 
USA) and repeatedly weighed until a constant weight was achieved. The void fractions 
were calculated using Equation (42) where Mi is mass, HG is hydrated hydrogel, DG is 
dehydrated hydrogel, and ρi is density.   
ε = VtÇÈitÈÉyÊËÌÍÊv 	[ VtÇÈÉÇÈ[Î 		 42	
Densities were calculated using mass and volume data obtained from 
photographic dimensional analysis and gravimetrical weights.  This method for void 
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volume determination is similar to methods outlined by Karageorgiou [147]; however, 
only open voids, voids which water may access, are considered in this method.  This is 
reasonable for this analysis as only voids filled by water will have enzymatically active 
chymotrypsin.  The peptide conjugated chromogen, Suc-AAPF-pNa, was covalently 
linked to the fully hydrated and swollen hydrogel using EDC and Sulfo-NHS to couple 
the chromogen’s carboxyl terminus to the primary amine group of AEMA which had 
been effectively cross-linked into the hydrogel and sits pendant to the backbone.  To 
perform the covalent conjugation, Suc-AAPF-pNa was dissolved in MES buffer and 
centrifuged to remove any un-dissolved chromogen. The dissolved concentration was 
determined by UV-Vis spectroscopy.  EDC was added to the dissolved chromogen 
solution creating a 1mM solution of EDC and allowed to incubate for 15 minutes to 
activate the carboxylic acid group on the chromogen. An aliquot of 0.3mL of the 
EDC/Chromogen solution was added to 0.9mL of a second solution containing the 
hydrogel disk and Sulfo-NHS in PBS.  The final reaction solution contained 5mM Sulfo-
NHS and was allowed to react for 2 hours under constant shaking. Following the 
conjugation reaction, the hydrogel discs were  extracted into multiple changes of 
Tris/KCl/CaCl (100/100/50 mM at pH = 7.4) buffer to remove any un-conjugated, 
absorbed chromogen. The release of physically entrapped chromogen was monitored by 
assaying the solvent extract until no further chromogen release could be detected.  This 
ensured that, once the hydrogel slab was placed in the chymotrypsin solution, any 
measured release of the chromogen was from the enzymatic cleavage of the peptide bond 
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of the covalently immobilized chromogen.  This procedure was performed for both Study 
A and Study B and is illustrated in Figure 2. 
 
Figure 2:  Schematic of hydrogel preparation and chromophore release process.  (1)  
Cross-linking of hydrogel components to create disks.  (2)  Solvent extraction and 
hydration of hydrogel disks.  (3)  Covalently linkage of chromophore to hydrogel by 
EDC/Sulfo-NHS chemistry.  (4) Removal of unreacted chromophore and reagents leaving 
only cross-linked chromophore.  (5) Incubation of hydrogel disks in chymotrypsin 
solution releasing chromogen which is measured with UV-Vis spectroscopy. 
2.2.2  Controlled Release of Chromophore from Hydrogel 
Once all entrapped chromogen was removed, hydrogel discs were separately 
added to a continuously agitated 5 unit / mL solutions of chymotrypsin in Tris/KCl/CaCl 
(100/100/50 mM at pH = 7.4) buffer. The solution was periodically aliquoted and each 
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aliquot was analyzed by UV-Vis Spectroscopy using a Synergy Mx Monochromator-
Based Multi-Mode Microplate Reader X (BioTek Instruments, Inc., Winooski, VT USA) 
to determine the concentration of the released chromophore.  Samples were kept at 
constant volume by making up the removed volume from the sample with fresh buffer.  
Dilution of the solution was accounted for in concentration calculations.  
2.2.3  Enzyme and Chromophore Characterization 
In order to study the concentrations of the released chromophore a calibration 
curve (ranging from 0.0 - 0.40mM in 0.04mM increments) was created to confirm its 
extinction coefficient, and a spectrum scan from 230 to 900 nm wavelengths was 
performed to determine the peak absorbance.  To measure the enzymatic activity of 
chymotrypsin with the targeted peptide sequence in the chromogen, initial enzymatic rate 
data were obtained for increasing concentrations (ranging from 0.010 - 0.100mM) of 
chromogen in Tris/KCl/CaCl buffer (100/100/50 mM at pH = 7.4 and T = 37oC).  A 
Lineweaver-Burke and Hill analysis was performed to determine the enzyme’s catalytic 
constant, kcat, the Michaelis constant, KM, and the Hill exponent, n. 
2.3.  Results and Discussions 
2.3.1  Enzyme and Chromophore Characterization 
The determined extinction coefficient was 10,430 ± 90 M-1cm-1 at 380 nm, Figure 
3 (Middle, imbedded). This value is similar to previously reported values of the 
extinction coefficient which was 9,900 M-1cm-1 at 410 nm [148].  Chymotrypsin is 
known to cleave preferentially at large aromatic peptides in the P1 position[149]; 
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therefore Suc-AAPF-pNa was cleaved at Phe releasing the UV active p-Nitroanilide.  The 
spectrum scan yielded only one peak which was associated with p-Nitroanilide.  The 
concentrations of dissolved chromogen in the conjugating solution were determined to be 
0.57mM and 0.20mM for studies A and B, respectively. 
The experimentally determined values for chymotrypsin’s kinetic parameters 
were, kcat = 9.39 ± 0.63 s-1,KM = 1.60x10-2 ± 0.47x10-2 mM, and n = 0.97 ± 0.02 (raw data 
not shown). These values differ from those found and reported by Wesolowska (kcat = 
77s-1 and KM = 8.7 x10-3 mM). The variations in kcat and KM may be attributed to different 
experimental temperatures (37oC versus 22oC), ion type (KCl versus NaCl), ion 
concentration, and/or pH(7.4 versus 8.4)[150]. 
2.3.2 Effect of Conjugating Amine Groups on Loading 
Changes in chromogenic substrate loading were achieved by increasing the mol% 
of AEMA, which has an amine pendant group, within the hydrogel.  Time-dependent 
cumulative release profiles, release rate, equilibrium concentrations, and Loading-
Release Efficiency (EL-R) all exhibited a positive correlation to increasing AEMA mol%, 
Figure 9. Figure 9A shows the kinetics of release of pNa as a function of the mol% of 
AEMA that was included in the hydrogel formulation. Both the initial rate of release and 
the amount released at t∞, M∞, show a clear dependence upon the mol% of AEMA, 
Figures 9A and 9B.  Additionally, from Figure 9B, it is apparent that the increase in void 
fraction for hydrogels greater than 5% is negligible.  This suggests there to be little effect 
on the Deff for increasing AEMA mol%.  Therefore for these hydrogels, the initial rate 
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increase can be attributed to greater substrate loading from more primary amine groups 
available for chromogen conjugation within the hydrogel.  
 
Figure 9:  (A) A plot of the released concentration of chromophore after cleavage of its 
peptide sequence by chymotrypsin as a function AEMA mol%.  (B) A plot of the void 
fraction (left y-axis) and release rate (right y-axis) as a function of AEMA mol%.  (C) A 
plot of EL-R of the chromogen after cleavage of its conjugated peptide sequence by 
chymotrypsin as a function of AEMA mol%, and the spectrum scan of p-Nitroanilide after 
it has been cleaved from the peptide sequence.   
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The total amount of released chromophore from an enzymatically active substrate 
conjugated to a hydrogel matrix could be affected by the yield of the conjugation 
chemistry as well as by access of the enzyme to the covalently tethered substrate within 
the hydrogel. The peptide-to-hydrogel conjugation reaction will limit the amount of 
conjugated species through reaction equilibrium, and this in turn will influence the 
amount of subsequently released species. Additionally, only conjugated chromogen 
within voids to which the catalytically active enzyme has access could be potentially be 
released. Figure 9C shows the achieved Loading and Release Efficiency, EL-R, which was 
calculated using Equation (43). 
EÏiÐ = tÑ	tÒ × 100%	 43	
Where M∞ is the amount of released chromophore at equilibrium, and MI is the amount of 
chromogen in the conjugating solution. This plot reflects the combined efficiency of 
peptide-to-hydrogel conjugation and release through enzymatic cleavage of a peptide 
bond as a function of increasing mol% of the conjugatable primary amine on AEMA.  
It is not possible to distinguish from an examination of initial release rates or 
loading-release efficiencies if the conjugation reaction yield or enzymatic access to 
immobilized chromogen is limiting the amount of chromophore released from the 
hydrogels; however, the constant equilibrium values of released chromophore for varying 
mol% TEGDA, Table 4, provides some insight into the limiting factor.  As cross-linked 
density is increased the hydrogel void volumes are reduced. If enzymatic access was 
affecting the amount of chromophore released from the hydrogels, it would be expected 
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that reducing the void volumes, effectively reducing voids within the hydrogel to which 
the enzyme has catalytic access, would reduce the final equilibrium value of released 
chromophore.  This is not the case as there is no change in the final released amounts, 
M∞, of the chromophore with increasing cross-link density. The fundamental factor 
controlling the loading is likely reaction equilibrium.  As AEMA mol% is increased 
reaction equilibrium is forced further to the right resulting in high chromogen loading.  
Controlling reaction yield by a hydrogel monomer constituent, such as AEMA, may be a 
valuable approach if the species being conjugated is scarce in supply.  This is often the 
case in biological applications as peptide motifs and other conjugated species are often 
associated with high cost and production time.  
2.3.2 Effect of Cross-linked Density on Release 
It may be desirable to control the release rate independent of substrate loading.  
To accomplish this, variations in enzyme access were controlled through the mol% of the 
cross-linker, TEDGA.  Figure 10A shows a plot of the released concentration of 
chromophore following enzymatic cleavage of the peptide chromogen by chymotrypsin 
as a function TEGDA mol%. The cumulative release profiles of the chromophore showed 
a negative correlation with increasing TEGDA concentration. This is an expected result 
which is best analyzed qualitatively by considering forces at work within the system.  
Increasing TEGDA concentration, which controls the cross-link density, increases the 
onset of the retractive mechanical forces binding the polymer chain segments together.  
In opposition to the mechanical forces is the osmotic pressure difference between the 
hydrogel and bulk solution. As cross-linking increases, and consequently the mechanical 
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forces, the osmotic pressure is less able to drive water into the hydrogel resulting in a 
reduced degree of hydration.  The reduction in hydration with increasing cross-linked 
density was measured experimentally and is reported in Table 5. 
The reduction in hydration reduces the void volume of the hydrogel within which 
the catalytically active enzyme can diffuse and in so doing, the effective diffusivity of the 
enzyme through the hydrogel matrix is reduced.  The reduction in effective diffusivity 
due to void fraction is commonly modeled using porous media model theory [119, 151].  
The second parameter in the porous media model, Equation (44), which is affected by the  
cross-linked density is the tortuosity, τ, connecting the voids within the hydrogel. 
D¢qq = D+ ÕÖ		 44	
τ = ÏÏu	 45	
As the cross-link density is increased the true molecular diffusion path length, L, 
increases relative to the length of the displacement path, Lc [152].  The increase in τ also 
contributes to the reduced effective diffusivities.  Tortuosities were calculated using 
Equation (45) after effective diffusivities, Deff, the diffusivity in buffer, D0, and void 
fractions, ε, were determined.  Figure 10B shows the effect of cross-linked density on ε 
and τ.  By comparing the degree of change between ε and τ for increasing cross-linked 
density, it becomes apparent that increases in τ are the primary cause of a decreasing Deff 
since τ increases two orders of magnitude over the range of TEGDA mol% while ε is 
reduced by only 50%. 
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Figure 10:  (A)  A plot of the released concentration of chromophore after cleavage of its 
peptide sequence by chymotrypsin as a function TEGDA mol%.  (B) A plot of the void 
fraction (left y-axis) and tortuosity (right y-axis) as a function of TEGDA mol%..  (C) A 
plot of the release rates of the chromophore after cleavage of its conjugated peptide 
sequence by chymotrypsin as a function of TEGDA mol%. 
Figure 10C demonstrates the reduction in release rates that could be expected for 
increasing amounts of TEGDA.  Following analysis which determined the system to be 
mass transport limited, the calculated release rates, shown in Figure 10C, were fit to an 
exponential decay.  The observed changes in effective diffusivities were best fit by an 
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exponential decay, and thus, the release rates are expected to follow the same trend since 
mass transport is the limiting mechanism. To verify that cross-linked density was not 
affecting the loading of the chromogen the final released moles of chromophore, M∞, 
were determined, Table 5.  A constant amount of chromophore was released at 
equilibrium across varying cross-linked densities indicates the variations in cross-linked 
densities did not affect substrate loading. 
Effective diffusivities of chymotrypsin through the hydrogel matrices were 
determined through a Thiele moduli analysis. Effectiveness factors and Thiele moduli 
were calculated using Equations (46) and (47) respectively [153], where η is the 
effectiveness factor, rapparent is the experimentally measured rate, and rintrinsic is the rate of 
reaction of the enzyme in a bulk solution of substrate.  Effectiveness factors were 
determined from experimentally determined initial rates r0,apparent, and theoretical intrinsic 
rates, r0,intrinsic, determined from Equation (48).	
η ≡ «ÚÚ}mvÍ«vÍ}vyu 	 46	
η = VÛ[ V hÜ#Û− #Û[	 47 
For the intrinsic rate calculation, the previously determined Vmax and KM were 
used in Equation (48), and the initial concentrations of the covalently attached substrate, 
[M*], were approximated by Equation (49).  There was an observed increase in the 
values of [M*] for increasing cross-linked density; however, this can be attributed to the 
decreasing hydrogel volume, that is, less swelling of the hydrogel since, M∞, was 
constant across cross-linked densities. 
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r+,£h«£h£ = nÞßat∗eàákat∗e 	 (48)	
aM∗e = nyÊËÌÍÊvatÑenãmËÕ 	 (49)	
The Thiele moduli shown in Table 5 were in all cases >> 1 which is characteristic 
of extremely mass transport limited system [154]. Since the release requires a large 
molecule, chymotrypsin (25 kDa), to diffuse into the hydrogel, the mass transport 
limiting characteristic of this system is expected.  The effective diffusivity constants, Deff, 
for varying cross-link density were then calculated by Equation (50) 
φ = Ð¿ å
nÞß
àáæmÁÁ
ç
 Î 	 (50)	
Where R is the characteristic length, α is 2 (α = 1, 2, or 3 for slabs, cylinders, or spheres, 
respectively) [144], φ is the Thiele modulus, and KM and Vmax are  the enzyme kinetic 
constants. The values of these calculations are summarized in Table 5.  
Table 5: Calculated parameters for varying cross-linked densities determined from the 
analysis of experimentally measured rate data. 
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D0 of chymotrypsin was calculated using an empirical fit to the effective 
diffusivities vs. Degree of Hydration and extrapolating to 100% hydration, representing 
pure buffer solution.  Degree of Hydration was calculated using Equation (51) [145].   
Degree	of	Hydration	(%) = tÇÈitÈtÇÈ × 100%	 (51)	
The D0 value determined in this way was found to be 6.9 ± 0.5 × 10-7 cm2 s-1. This value 
is only slightly larger when compared to 5.3 ± 0.2 × 10-7 cm2 s-1 determined for a simple 
phosphated adduct of the 25kDa chymotrypsin [155, 156].  The small increase may be 
due to the partitioning of chymotrypsin into the hydrogel.  The partition coefficient for 
chymotrypsin into the poly(HEMA)-based hydrogel was not determined for this work; 
however, Equation (44) can be modified to account for this effect by including a partition 
coefficient, Kp, Equation (52). 
D¢qq = KñD+ò ÕÖ	 (52)	
Without determining the partitioning coefficient, the calculated D0 value is a 
lumped parameter equal to the multiple of D0’ and Kp, and it includes any partitioning 
effects.  The contribution of this effect is believed to be small because the D0 in this work 
is similar to that of others.  The diffusion rate of chymotrypsin in an uncrosslinked 
polymer was calculated using an empirical fit to the effective diffusivities vs. TEGDA 
mol% and was determined to be 9.5 ± 0. 3 ×10-5 cm2 s-1.  These values are akin to the 
diffusivity of chymotrypsin within crowded media [156]. 
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2.3.3 Using Thiele Moduli to Optimize Drug Delivery Systems 
In the design of biologically responsive hydrogel drug delivery systems within 
which proteases are used to cleave and hence initiate and provoke a release response, 
Equation (50) may be used to optimize critical parameters for such systems.  The optimal 
system will be one in which the release rate is kinetically limited, that is, when φ << 1 
[154]. To illustrate analysis of such a system, the case where rapparent is 99% of rintrinsic will 
be considered (i.e. η=0.99, φ=0.13).  Breaking the equation into biological intrinsic 
properties, Vmax and KM, and design parameters, R, α, and Deff, allows a maximum value 
of R to be calculated where mass transport is not limiting, (R α-1)max.  R is the 
characteristic dimension of the system; for slabs it is the length of the dimension parallel 
to the direction of transport and for cylinders and spheres it is the radii.  α is a constant 
resulting from the derivation of Equation (50) and has a value of 1, 2, or 3 for slab, 
cylindrical, or spherical geometries, respectively.  Figure 5 demonstrates this relationship 
for varying effective diffusivities of the protease enzyme.   
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Figure 11: A plot of the maximum characteristic dimension of a hydrogel which will not 
have mass transport limitations as a function of effective diffusivity and KM Vmax-1. 
To illustrate how Figure 10 may be used to optimize a bio-responsive hydrogel 
which uses enzymatic cleavage for release, consider the case of the 5 mol% TEGDA 
cross-linked hydrogel disks in this study. For this composition the ratio of KMVmax-1 is 
calculated to be 10.9 seconds.  The effective diffusivity for these disks was 1.4 × 10-8 
cm2/s.  From Figure 10, this corresponds to a (R α-1)max value of 1.5 μm.  For the 
cylindrical geometry of our discs α = 2, so the optimized cylinder would have a radii of 
0.75 μm.  A similar analysis could be performed on planar (α = 1) or spherical (α = 3) 
geometries.  Bio-responsive hydrogel spheres and thin films used in biological 
applications could benefit from such an analysis since altering the characteristic 
dimension could move the system from mass transport limited to a kinetically limited 
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regime.  This would maximize the release rate from the hydrogel which is one of the 
most significant weaknesses of these systems [76].  
2.4. Remarks and Conclusions 
The release of the chromophore, a surrogate for a drug, in this study occurred by 
the diffusion of the protease enzyme into a poly(HEMA)-based hydrogel, and then by the 
subsequent enzymatic cleavage of a targeted peptide sequence caused the release of an 
elutable chromophore from the hydrogel network. The rate-limiting step in this process 
will typically be mass transport due to the low effective diffusivities of large proteases 
into the hydrogel; however, the hydrogel size, shape, and cross-linked density may serve 
as design criteria with which to balance or remove the transport limitations in order to 
achieve programmed release from such systems.  While this work used a chromophore 
and the enzyme chymotrypsin, similar systems could be designed using therapeutic drugs 
and other specific proteases in lieu of these molecules. 
The amount of an enzymatically active substrate loaded into a hydrogel matrix 
can be controlled by varying the amount of conjugating monomer that is polymerized 
into the hydrogel backbone.  The amount of the substrate loaded and released would then 
depend upon the conjugation chemistry as well as enzymatic access to the covalently 
bound substrate; however, the loading in this study was found to depend primarily on the 
equilibrium of the conjugation chemistry.  For systems which have lower hydrogel void 
fractions (<40%) or are using large proteins (>25kDa), enzyme access may need to be 
considered in yield calculations.  The release rate from the hydrogel after cleavage was 
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affected by both the amount of hydrophilic, conjugating monomer and cross-linked 
density.  To control the release rate cross-linked density can be changed without affecting 
the substrate loading.  In targeted drug-delivery, controlling the amount of drug delivered 
and rate at which it is delivered independently can serve as a valuable design 
methodology.  This study investigated a methodology of engineering a bio-responsive 
hydrogel which could achieve this goal.   
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CHAPTER 3:  FUTURE WORK 
The goal of future work in enzymatically actuated bioresponsive hydrogels will 
be continued investigation of methods and theories which will allow for better control 
over sensing, transduction, and response in these materials.  To this end, pre-
polymerization loading methodologies will be investigated in vitro, in silico diffusion-
reaction multiphysics modeling will be performed to match experimental data, and 
enzyme actuated degradation of the polymer will be engineered as a material capability.   
Pre-polymerization loading will involve the synthesis of acryolyl-peptide 
conjugates; its subsequent separation, purification, and analysis; and finally, its inclusion 
into the monomer cocktail prior to UV polymerization of the matrix.  Pre-polymerization 
loading may allow for higher loading efficiencies and/or further investigation into the 
conjugates’ in vitro properties (i.e. enzyme kinetic parameters for the solution phase 
conjugate).  Therefore, pre-loaded hydrogels will be synthesized and the results will be 
compared to the previously discussed study in Chapter 2 to interrogate pros and cons of 
both methods. 
 In silico modeling of enzymatically actuated hydrogels will be investigated.  
These models will serve as confirmation to the theories of kinetic, thermodynamic, and 
transport phenomena.  Additionally, they will serve as optimization and experimental 
guidance tools for other systems wherein system parameters (ie. KM, kcat [E]T, [M*], Deff, 
etc.) could be altered.  COMSOL Multiphysics will be used as the primary modeling 
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software.  Transport models discussed in Chapter 1 will be used in conjugation with the 
FEM models and experimental data. 
Creating a hydrogel which is able to degrade in response to enzyme activity will 
be a final goal of future work.  In order to confer erosion capabilities to the polymer 
backbone the labile cross-linker, TEGDA, will be substituted by a diacrylate-peptide that 
is enzymatically active.  The work outline in Chapter 2 demonstrated enzyme diffusion 
control by varying cross-linking concentration.  As the concentration of cross-linker is 
increased diffusion of proteases diffusivity constants drop exponentially.  This will 
subsequently reduce the amount of enzyme available to cleaving the backbone-integrated 
peptide and reduce the rate of erosion; however, as concentration of erodible cross-linker 
increases the number of cleavable sites will increase, thus increasing the rate of erosion.  
These competing phenomena generate a high order of complexity in understanding how 
to control erosion rates.  Investigation of this system will proceed by experimental 
degradation by enzymatic erosion and subsequently the erosion rates will be analyzed in 
view of surface, bulk, or moving front erosion theories. 
This work will contribute to the core understanding of increasingly complex 
bioresponsive hydrogel systems.  It will serve as platform theories and methods for 
applications in drug delivery, sensors, and tissue engineering.  The continued integration 
of bioresponsive hydrogels guarantees the demand and need for sustained research and 
development in this field, and it promises to deliver technologies which will better serve 
civilian, military, and medical industries. 
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